Risk factors for HIV infection in german i.v. drug abusers
- 1 April 1987
- journal article
- conference paper
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 65 (8) , 376-379
- https://doi.org/10.1007/bf01745578
Abstract
A series of 320 German i.v. drug abusers (32.2% female, 67.8% male) were tested in a cross-sectional study for antibodies against HIV. Seroprevalence increased from 0 in those who discontinued i.v. drug abuse before 1982 to 37.2% in those who stopped injecting drugs in 1985/1986 or who were still addicted. Antibodies to HIV were significantly associated with lymphadenopathy and clinical symptoms (fever, weight loss, diarrhea, fatigue, night sweat, dermal lesions) and with markers of hepatitis A and hepatitis B virus infection. Participants of the study admitted in 92.5% of cases to “needle sharing” and in 83.1% of cases to sexual contacts among drug abusers. Prostitution and drug abuse in prison were significantly correlated with seropositivity. No antibodies to HIV infection were detected in 131 subjects of a control group of household contacts.Keywords
This publication has 17 references indexed in Scilit:
- HTLV-III ANTIBODY IN DRUG ABUSERS IN THE WEST OF SCOTLAND: THE EDINBURGH CONNECTIONThe Lancet, 1986
- Zunahme der Prävalenz von Antikörpern gegen LAV/HTLV III bei Drogenabhängigen in der Bundesrepublik DeutschlandDeutsche Medizinische Wochenschrift (1946), 1986
- HTLV-III ANTIBODY IN EDINBURGH DRUG ADDICTSThe Lancet, 1985
- HTLV-III ANTIBODY IN SWISS AND ENGLISH INTRAVENOUS DRUG ABUSERSThe Lancet, 1985
- HTLV-III ANTIBODY AMONG ITALIAN DRUG ADDICTSThe Lancet, 1985
- Lymphadenopathy and antibodies to HTLV-III in homosexual menJournal of Molecular Medicine, 1985
- HTLV-III ANTIBODIES IN DRUG ADDICTS IN SPAINThe Lancet, 1985
- HIGH FREQUENCY OF HTLV-III ANTIBODIES AMONG HETEROSEXUAL INTRAVENOUS DRUG ABUSERS IN THE AUSTRIAN TYROLThe Lancet, 1985
- Virologic Studies in a Case of Transfusion-Associated AIDSNew England Journal of Medicine, 1985
- Seroepidemiology of HTLV-III (LAV) in the Federal Republic of GermanyJournal of Molecular Medicine, 1985